Back to today’s briefing

Story perspectives

University of Missouri Advances RNA Therapy for Genetic Conditions

10/15/2025

50 10

Summary

Story summary

The University of Missouri is pursuing RNA-based therapy for Marfan syndrome, funded by the American Heart Association.
Dunpeng Cai aims to correct mutated RNA, potentially curing Marfan syndrome and affecting other genetic conditions.
The approach could advance precision medicine by tailoring treatments to individual genetic profiles.
A Cyprus project pursues a one-time cure for ?-thalassemia with base editing, targeting HBBIVSI-110.

1 of 1

Story summary

The University of Missouri is pursuing RNA-based therapy for Marfan syndrome, funded by the American Heart Association.
Dunpeng Cai aims to correct mutated RNA, potentially curing Marfan syndrome and affecting other genetic conditions.
The approach could advance precision medicine by tailoring treatments to individual genetic profiles.
A Cyprus project pursues a one-time cure for ?-thalassemia with base editing, targeting HBBIVSI-110.